+1,247.6%
PANW vs GSK
+97.7%
+1,149.9%
-48.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.4% | -1.6% | +8.0% | +6.7% |
| 7D | +12.1% | -4.7% | +16.8% | +13.1% |
| 30D | +6.3% | -4.7% | +11.0% | +7.2% |
| 3M | +0.5% | -8.8% | +9.3% | +2.2% |
| 6M | +50.6% | -4.6% | +55.3% | +51.2% |
| YTD | +96.4% | +1.0% | +95.4% | +92.4% |
| 1Y | +81.0% | +6.9% | +74.1% | +74.6% |
| 3Y | +192.2% | +52.5% | +139.7% | +149.1% |
| 5Y | +309.2% | +40.3% | +269.0% | +253.4% |
| All | +1,247.6% | +97.7% | +1,149.9% | +831.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling